» Authors » Andrew A Wagner

Andrew A Wagner

Explore the profile of Andrew A Wagner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 100
Citations 1134
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Waisman Malaret A, Chang P, Newcomb L, Faino A, Zheng Y, Zhu K, et al.
Urol Pract . 2023 May; 8(5):576-582. PMID: 37145399
Introduction: We analyzed the Canary Prostate Cancer Active Surveillance (PASS) cohort to determine if patients who had diagnostic biopsy at an off-site practice were at higher risk of reclassification than...
12.
Alam R, Yerrapragada A, Wlajnitz T, Watts E, Pallauf M, Enikeev D, et al.
Eur Urol Open Sci . 2023 Apr; 50:78-84. PMID: 37101773
Background: As the adoption of active surveillance (AS) for small renal masses (SRMs) grows, the number of elderly patients enrolled for a prolonged period of time will increase. However, our...
13.
Schenk J, Liu M, Neuhouser M, Newcomb L, Zheng Y, Zhu K, et al.
Nutr Cancer . 2022 Nov; 75(2):618-626. PMID: 36343223
Modifiable lifestyle factors, such as following a healthy dietary pattern may delay or prevent prostate cancer (PCa) progression. However, few studies have evaluated whether following specific dietary patterns after PCa...
14.
Houenstein H, Jing Z, Elsayed A, Ramahi Y, Stockle M, Wijburg C, et al.
Urology . 2022 Oct; 171:133-139. PMID: 36241062
Objective: To identify trends in complications following robot-assisted radical cystectomy (RARC) using a multi-institutional database, the International Robotic Cystectomy Consortium (IRCC). Methods: A retrospective review of the IRCC database was...
15.
Garnick M, Wagner A
Urology . 2022 Jul; 165:235. PMID: 35843696
No abstract available.
16.
Filson C, Zhu K, Huang Y, Zheng Y, Newcomb L, Williams S, et al.
J Urol . 2022 Jul; 208(5):1037-1045. PMID: 35830553
Purpose: We assessed whether Prostate Health Index results improve prediction of grade reclassification for men on active surveillance. Methods And Materials: We identified men in Canary Prostate Active Surveillance Study...
17.
Brady L, Newcomb L, Zhu K, Zheng Y, Boyer H, De Sarkar N, et al.
Cancer Med . 2022 Apr; 11(22):4332-4340. PMID: 35467778
Background: Pathogenic germline mutations in several rare penetrant cancer predisposition genes are associated with an increased risk of aggressive prostate cancer (PC). Our objectives were to determine the prevalence of...
18.
Elsayed A, Iqbal U, Jing Z, Houenstein H, Wijburg C, Wiklund P, et al.
Urology . 2022 Apr; 166:177-181. PMID: 35461914
Objectives: To investigate the oncologic outcomes of pT0 after robot-assisted radical cystectomy (RARC). Methods: A retrospective review of the International Robotic Cystectomy Consortium database was performed. Patients with pT0 after...
19.
Stensland K, Delto J, Ramesh N, Robertson C, Schober J, Chang P, et al.
Can J Urol . 2022 Apr; 29(2):11080-11086. PMID: 35429426
Introduction: To assess the association between postoperative discharge day after minimally invasive partial nephrectomy with 30-day readmission rates, and specifically compare postoperative day 1 to postoperative day 2 discharge. We...
20.
Gopalakrishnan D, Elsayed A, Hussein A, Jing Z, Li Q, Wagner A, et al.
Int J Urol . 2021 Dec; 29(3):197-205. PMID: 34923677
Objectives: To analyze the impact of neoadjuvant chemotherapy on survival and recurrence patterns in muscle-invasive bladder cancer after robot-assisted radical cystectomy. Materials And Methods: The International Robotic Cystectomy Consortium database...